14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARIA
Delisted

ARIAD Pharmaceuticals Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Mar 13, 2017

Range Low Price High Price Comment
30 days $23.87 $23.99 Monday, 13th Mar 2017 ARIA stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $11.69 $23.99
52 weeks $6.02 $23.99

Historical ARIAD Pharmaceuticals prices

Date Open High Low Close Volume
Feb 03, 2017 $23.78 $23.81 $23.78 $23.80 5 497 843
Feb 02, 2017 $23.80 $23.82 $23.77 $23.79 9 809 445
Feb 01, 2017 $23.81 $23.84 $23.74 $23.79 11 893 755
Jan 31, 2017 $23.80 $23.85 $23.80 $23.82 14 659 747
Jan 30, 2017 $23.66 $23.71 $23.65 $23.65 9 167 373
Jan 27, 2017 $23.65 $23.75 $23.63 $23.68 8 097 413
Jan 26, 2017 $23.71 $23.73 $23.63 $23.64 14 178 936
Jan 25, 2017 $23.73 $23.76 $23.70 $23.72 11 316 230
Jan 24, 2017 $23.73 $23.75 $23.70 $23.74 11 675 020
Jan 23, 2017 $23.74 $23.78 $23.71 $23.71 9 037 397
Jan 20, 2017 $23.73 $23.80 $23.72 $23.75 11 612 337
Jan 19, 2017 $23.72 $23.73 $23.68 $23.70 12 935 191
Jan 18, 2017 $23.66 $23.73 $23.66 $23.70 11 922 495
Jan 17, 2017 $23.67 $23.72 $23.64 $23.64 13 069 735
Jan 13, 2017 $23.69 $23.71 $23.67 $23.69 14 657 842
Jan 12, 2017 $23.70 $23.71 $23.68 $23.71 14 659 283
Jan 11, 2017 $23.70 $23.73 $23.65 $23.70 35 794 296
Jan 10, 2017 $23.75 $23.79 $23.68 $23.68 62 148 597
Jan 09, 2017 $23.78 $23.81 $23.71 $23.75 142 428 992
Jan 06, 2017 $13.49 $13.99 $13.46 $13.74 4 207 041
Jan 05, 2017 $13.11 $13.47 $12.82 $13.40 4 565 542
Jan 04, 2017 $12.40 $13.30 $12.40 $13.06 6 980 414
Jan 03, 2017 $12.59 $12.73 $12.12 $12.37 2 755 693
Dec 30, 2016 $12.39 $12.60 $12.37 $12.44 2 449 754
Dec 29, 2016 $12.54 $12.71 $12.36 $12.40 2 282 195
Click to get the best stock tips daily for free!

About ARIAD Pharmaceuticals

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of drugs for cancer patients in the United States and internationally. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, the European Union, Australia, Switzerland... ARIA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT